Recombinant multi-species FcRn/FCGRT protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine FcRn/FCGRT protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a receptor that binds the Fc region of monomeric immunoglobulin G. The encoded protein transfers immunoglobulin G antibodies from mother to fetus across the placenta. This protein also binds immunoglobulin G to protect the antibody from degradation. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2009]
The Alternative Names of target: FCGRT,FCRN,FcRn,FcgammaRn,Fcgrt,IgG Fc fragment receptor transporter alpha chain,IgG receptor FcRn large subunit p51,Neonatal Fc receptor,alpha-chain

Target products collectionGo to FcRn/FCGRT products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP0110-Ag-1/ GM-Tg-hg-IP0110-Ag-2 Human FcRn/FCGRT protein Human
GM-Tg-rg-IP0110-Ag-1/ GM-Tg-rg-IP0110-Ag-2 Rat FcRn/FCGRT protein Rat
GM-Tg-mg-IP0110-Ag-1/ GM-Tg-mg-IP0110-Ag-2 Mouse FcRn/FCGRT protein Mouse
GM-Tg-cynog-IP0110-Ag-1/ GM-Tg-cynog-IP0110-Ag-2 Cynomolgus/Rhesus macaque FcRn/FCGRT protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP0110-Ag-1/ GM-Tg-felg-IP0110-Ag-2 Feline FcRn/FCGRT protein Feline
GM-Tg-cang-IP0110-Ag-1/ GM-Tg-cang-IP0110-Ag-2 Canine FcRn/FCGRT protein Canine
GM-Tg-bovg-IP0110-Ag-1/ GM-Tg-bovg-IP0110-Ag-2 Bovine FcRn/FCGRT protein Bovine
GM-Tg-equg-IP0110-Ag-1/ GM-Tg-equg-IP0110-Ag-2 Equine FcRn/FCGRT protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP0110-Ag-1/ GM-Tg-hg-IP0110-Ag-2; GM-Tg-rg-IP0110-Ag-1/ GM-Tg-rg-IP0110-Ag-2;
GM-Tg-mg-IP0110-Ag-1/ GM-Tg-mg-IP0110-Ag-2; GM-Tg-cynog-IP0110-Ag-1/ GM-Tg-cynog-IP0110-Ag-2;
GM-Tg-felg-IP0110-Ag-1/ GM-Tg-felg-IP0110-Ag-2; GM-Tg-cang-IP0110-Ag-1/ GM-Tg-cang-IP0110-Ag-2;
GM-Tg-bovg-IP0110-Ag-1/ GM-Tg-bovg-IP0110-Ag-2; GM-Tg-equg-IP0110-Ag-1/ GM-Tg-equg-IP0110-Ag-2
Products Name FcRn/FCGRT protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name FcRn/FCGRT
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine FcRn/FCGRT protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.